{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:20:26Z","timestamp":1794298826333,"version":"4.9.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.neuroscience.2015.05.037","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T18:41:54Z","timestamp":1432579314000},"page":"68-83","source":"Crossref","is-referenced-by-count":254,"special_numbering":"C","title":["Imaging of autoimmune encephalitis \u2013 Relevance for clinical practice and hippocampal function"],"prefix":"10.1016","volume":"309","author":[{"given":"J.","family":"Heine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Pr\u00fcss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Ploner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7665-1171","authenticated-orcid":false,"given":"C.","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2015.05.037_b0005","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.80.7_supplement.P06.222","article-title":"FDG\u2013PET Reveals reduced metabolic activity in the basal ganglia of a patient with anti-NMDA receptor encephalitis","volume":"80","author":"Abers","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.parkreldis.2014.02.015","article-title":"Pure ataxia associated with N-methyl-d-aspartate receptor antibodies","volume":"20","author":"Aguiar de Sousa","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0015","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates","volume":"128","author":"Ances","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0020","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.0b013e3182152808","article-title":"Tonic seizures: A diagnostic clue of anti-LGI1 encephalitis?","volume":"76","author":"Andrade","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0025","doi-asserted-by":"crossref","first-page":"16720","DOI":"10.1073\/pnas.1208494109","article-title":"NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia","volume":"109","author":"Anticevic","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0030","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy","volume":"71","author":"Ari\u00f1o","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0035","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies","volume":"82","author":"Balint","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0040","series-title":"The clinical neurobiology of the hippocampus","first-page":"200","article-title":"The hippocampus in neurological disease","author":"Bartsch","year":"2012"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0045","doi-asserted-by":"crossref","first-page":"17562","DOI":"10.1073\/pnas.1110266108","article-title":"CA1 neurons in the human hippocampus are critical for autobiographical memory, mental time travel, and autonoetic consciousness","volume":"108","author":"Bartsch","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0050","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.1188160","article-title":"Focal lesions of human hippocampal CA1 neurons in transient global amnesia impair place memory","volume":"328","author":"Bartsch","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11307-008-0134-7","article-title":"Role of FDG\u2013PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates","volume":"10","author":"Basu","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.0b013e3181cb3e52","article-title":"Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor","volume":"74","author":"Bataller","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0065","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","article-title":"Cerebral FDG\u2013PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types","volume":"260","author":"Baumgartner","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13311-014-0264-3","article-title":"Autoimmune epilepsies","volume":"11","author":"Bien","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0075","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00415-013-6946-7","article-title":"Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas","volume":"260","author":"Boesebeck","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/brain\/83.3.357","article-title":"Subacute encephalitis of later adult life. Mainly affecting the limbic areas","volume":"83","author":"Brierley","year":"1960","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1590\/S0004-282X2011000300030","article-title":"Fluorodeoxyglucose positron emission tomography findings in NMDA receptor antibody encephalitis","volume":"69","author":"Caballero","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"issue":"Pt 8","key":"10.1016\/j.neuroscience.2015.05.037_b0100","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0105","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMcpc1100924","article-title":"Case records of the Massachusetts General Hospital. Case 34\u20132011: a 75-year-old man with memory loss and partial seizures","volume":"365","author":"Cash","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0110","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00415-009-5165-8","article-title":"Successive affection of bilateral temporomesial structures in a case of non-paraneoplastic limbic encephalitis demonstrated by serial MRI and FDG\u2013PET","volume":"256","author":"Chatzikonstantinou","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/91.3.481","article-title":"\u201cLimbic encephalitis\u201d and its association with carcinoma","volume":"91","author":"Corsellis","year":"1968","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0120","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/brain\/aws256","article-title":"Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders","volume":"135","author":"Dale","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0125","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0135","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/neuonc\/nou030","article-title":"Autoimmune encephalitis update","volume":"16","author":"Dalmau","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2014.04.009","article-title":"Opsoclonus-myoclonus syndrome and limbic encephalitis associated with GABAB receptor antibodies in CSF","volume":"272","author":"DeFelipe-Mimbrera","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0150","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/WNL.40.8.1304","article-title":"Evolution of brain MRI abnormalities in limbic encephalitis","volume":"40","author":"Dirr","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0155","article-title":"Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series","author":"Dogan Onugoren","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0160","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jns.2014.10.026","article-title":"Faciobrachial dystonic seizures and antibodies to Lgi1 in a 92-year-old patient: a case report","volume":"347","author":"Fidzinski","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","article-title":"Cognitive deficits following anti-NMDA receptor encephalitis","volume":"83","author":"Finke","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0170","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1523\/JNEUROSCI.0744-13.2013","article-title":"Neural correlates of short-term memory reorganization in humans with hippocampal damage","volume":"33","author":"Finke","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.23932","article-title":"Functional and structural brain changes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"74","author":"Finke","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2015.02.024","article-title":"Structural hippocampal damage following anti-NMDAR encephalitis","author":"Finke","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0185","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1097\/RLU.0b013e31824852c7","article-title":"Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis","volume":"37","author":"Fisher","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0190","article-title":"Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis","author":"Fleischmann","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0195","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1212\/WNL.0b013e31820c34de","article-title":"Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis","volume":"76","author":"Frechette","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0200","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The expanding clinical profile of anti-AMPA receptor encephalitis","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0210","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.35.4.538","article-title":"Neuronal antinuclear antibody in sensory neuronopathy from lung cancer","volume":"35","author":"Graus","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0215","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0220","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1212\/WNL.0b013e318293e334","article-title":"Administration of isoflurane-controlled dyskinetic movements caused by anti-NMDAR encephalitis","volume":"80","author":"Gumbinger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0225","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1212\/NXI.0000000000000002","article-title":"NMDA receptor antibodies associated with distinct white matter syndromes","volume":"1","author":"Hacohen","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/dmcn.12321","article-title":"N-methyl-d-aspartate receptor antibody-associated movement disorder without encephalopathy","volume":"56","author":"Hacohen","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0235","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"H\u00f6ftberger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch Neurol"},{"issue":"16","key":"10.1016\/j.neuroscience.2015.05.037_b0245","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0250","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal","volume":"70","author":"Iizuka","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0255","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s00415-010-5604-6","article-title":"Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study","volume":"257","author":"Iizuka","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0260","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0265","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0275","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jamaneurol.2014.463","article-title":"Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy","volume":"71","author":"Irani","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0280","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0290","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0295","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.12.006","article-title":"GABAB receptor antibodies in paraneoplastic cerebellar ataxia","volume":"256","author":"Jarius","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0300","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","article-title":"GABAB receptor autoantibody frequency in service serologic evaluation","volume":"81","author":"Jeffery","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0305","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ana.24224","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis with multiphasic demyelination","volume":"76","author":"Kaneko","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2014.02.011","article-title":"Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis","volume":"270","author":"Kim","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0315","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3174\/ajnr.A3633","article-title":"MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis","volume":"35","author":"Kotsenas","year":"2014","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0320","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamaneurol.2013.143","article-title":"Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab","volume":"70","author":"Krogias","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0325","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1684\/epd.2009.0237","article-title":"Non-paraneoplastic limbic encephalitis associated with antibodies to potassium channels leading to bilateral hippocampal sclerosis in a pre-pubertal girl","volume":"11","author":"Kr\u00f6ll-Seger","year":"2009","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0330","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jamaneurol.2013.4786","article-title":"Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of \u03b3-aminobutyric acid type B receptor autoimmunity","volume":"71","author":"Kruer","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0335","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/mds.25510","article-title":"Anti-N-methyl-d-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness","volume":"28","author":"Labate","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0340","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0345","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels : a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0350","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2014pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0355","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuroscience.2015.05.037_b0365","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0370","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4065\/78.11.1363","article-title":"Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis","volume":"78","author":"Lawn","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0375","article-title":"Autoimmune encephalopathies","author":"Leypoldt","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0380","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2011-301969","article-title":"Fluorodeoxyglucose positron emission tomography in anti-N-methyl-d-aspartate receptor encephalitis: distinct pattern of disease","volume":"83","author":"Leypoldt","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0385","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan\u2019s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0390","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuron.2006.03.026","article-title":"NMDA receptors, glial cells, and clinical medicine","volume":"50","author":"Lipton","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0395","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2011.08.024","article-title":"Morvan\u2019s syndrome associated with antibodies to multiple components of the voltage-gated potassium channel complex","volume":"312","author":"Loukaides","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0400","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.2009.198697","article-title":"FDG\u2013PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis","volume":"82","author":"Maeder-Ingvar","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0405","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00415-014-7408-6","article-title":"Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity","volume":"261","author":"Malter","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0410","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0415","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1177\/0883073811405199","article-title":"Novel FDG\u2013PET findings in anti-NMDA receptor encephalitis: a case based report","volume":"26","author":"Maqbool","year":"2011","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0420","first-page":"1","article-title":"Glycine receptor autoimmune spectrum with Stiff-man syndrome phenotype","author":"McKeon","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0425","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/RLU.0b013e3181db4d4a","article-title":"F-18 fluorodeoxyglucose PET\/CT findings in a case of anti-NMDA receptor encephalitis","volume":"35","author":"Mohr","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0430","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2013.04.004","article-title":"GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis","volume":"259","author":"Mundiyanapurath","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0435","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","article-title":"Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis","volume":"34","author":"Ohkawa","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0440","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/brb3.14","article-title":"Perfusion IMP-SPECT shows reversible abnormalities in GABA(B) receptor antibody associated encephalitis with normal MRI","volume":"1","author":"Ohta","year":"2011","journal-title":"Brain Behav"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0445","first-page":"335","article-title":"\u00dcber Hirnsymptome bei Carcinomatose ohne nachweisbare Ver\u00e4nderungen im Gehirn","volume":"13","author":"Oppenheim","year":"1888","journal-title":"Charit\u00e9-Annalen (Berlin)"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0450","article-title":"18F-FDG PET\/CT in anti-LGI1 encephalitis: initial and follow-up findings","author":"Park","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0455","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0460","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pediatrneurol.2010.04.019","article-title":"Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis","volume":"43","author":"Pillai","year":"2010","journal-title":"Pediatr Neurol"},{"issue":"Pt 1","key":"10.1016\/j.neuroscience.2015.05.037_b0465","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl-d-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planagum\u00e0","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0470","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0b013e31828f17fa","article-title":"Teaching NeuroImages: basal ganglia involvement in facio-brachial dystonic seizures associated with LGI1 antibodies","volume":"80","author":"Plantone","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0475","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.0b013e3182061b1e","article-title":"Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients","volume":"76","author":"Rubio-Agusti","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0480","first-page":"1","article-title":"Encephalomyelitis and carcinomatous neuropathy","volume":"13","author":"Russell","year":"1961","journal-title":"Encephalomyelitis"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0485","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0490","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/archneur.61.11.1785","article-title":"Serial 18F-fluoro-2-deoxy-d-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis","volume":"61","author":"Scheid","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0495","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2014.04.002","article-title":"Serial brain 18FDG\u2013PET in anti-AMPA receptor limbic encephalitis","volume":"271","author":"Spatola","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0505","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.wnl.0000336972.62597.41","article-title":"Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome","volume":"71","author":"Spinazzi","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0510","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1212\/WNL.0b013e318239c3d7","article-title":"Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?","volume":"77","author":"Striano","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0515","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.05.048","article-title":"Natural course of LGI1 encephalitis: 3\u20135years of follow-up without immunotherapy","volume":"343","author":"Szots","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0520","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.msard.2013.09.005","article-title":"A case of anti-N-methyl-d-aspartate receptor encephalitis with multiple sclerosis-like demyelinated lesions","volume":"3","author":"Takeda","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0525","first-page":"1566","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis: a patient with refractory illness after 25months of intensive immunotherapy","volume":"70","author":"Thomas","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0530","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.24117","article-title":"Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0535","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0540","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0545","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1212\/CPJ.0000000000000074","article-title":"NMDA receptor encephalitis causing reversible caudate changes on MRI and PET imaging","volume":"4","author":"Tobin","year":"2014","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0550","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000323751","article-title":"A young man with anti-NMDAR encephalitis following Guillain\u2013Barr\u00e9 syndrome","volume":"3","author":"Tojo","year":"2011","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0555","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/jnnp.2007.129882","article-title":"Functional imaging correlates of fronto-temporal dysfunction in Morvan\u2019s syndrome","volume":"79","author":"Toosy","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0560","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archneur.1976.00500090066014","article-title":"Cerebellar degeneration with Hodgkin disease","volume":"33","author":"Trotter","year":"1976","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.neuroscience.2015.05.037_b0565","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10072-013-1511-9","article-title":"Downbeat nystagmus as the initial manifestation of anti-NMDAR encephalitis","volume":"35","author":"Tsuyusaki","year":"2014","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0570","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2377-13-55","article-title":"Progressive striatal necrosis associated with anti-NMDA receptor antibodies","volume":"13","author":"Tzoulis","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0575","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00234-006-0069-0","article-title":"Serial MRI of limbic encephalitis","volume":"48","author":"Urbach","year":"2006","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0580","article-title":"Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions","author":"Varley","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0585","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0590","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.20614","article-title":"Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma","volume":"58","author":"Vitaliani","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0595","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/epi.12320","article-title":"Quantitative FLAIR analysis indicates predominant affection of the amygdala in antibody-associated limbic encephalitis","volume":"54","author":"Wagner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0600","article-title":"Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis","author":"Wagner","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0605","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2377-14-136","article-title":"Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-d-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography","volume":"14","author":"Wegner","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0610","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jneuroim.2013.05.011","article-title":"Rapid progression and brain atrophy in anti-AMPA receptor encephalitis","volume":"261","author":"Wei","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0615","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(64)91694-0","article-title":"Serological findings in carcinomatous neuromyopathy","volume":"283","author":"Wilkinson","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2015.05.037_b0620","first-page":"3","article-title":"Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder","author":"Wuerfel","year":"2014","journal-title":"J Neurol Sci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215004790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215004790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T05:55:05Z","timestamp":1717912505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452215004790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":124,"alternative-id":["S0306452215004790"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2015.05.037","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}